CGEM

Cullinan Oncology Inc

• TipRanks·1d ago

  JonesTrading Sticks to Their Buy Rating for Cullinan Management (CGEM)

• NASDAQ·03/27 15:30

  Commit To Purchase Cullinan Therapeutics At $9, Earn 25.1% Annualized Using Options

• TipRanks·03/24 18:50

  Clear Street says Gilead-Ouro deal highlights upside for Cullinan’s velinotamig

• TipRanks·03/16 12:37

  Morgan Stanley Sticks to Their Buy Rating for Cullinan Management (CGEM)

• TipRanks·03/13 02:25

  Stifel Nicolaus Sticks to Their Buy Rating for Cullinan Management (CGEM)

• Dow Jones·03/11 13:03

  Cullinan Therapeutics Is Maintained at Outperform by Wedbush

• Benzinga·03/11 12:53

  Wedbush Maintains Outperform on Cullinan Therapeutics, Raises Price Target to $36

• TipRanks·03/11 12:10

  Cullinan Therapeutics price target raised to $36 from $34 at Wedbush

• NASDAQ·03/11 11:07

  Cullinan Reports Wider Loss In Q4, Updates Milestones

• TipRanks·03/11 10:58

  Guggenheim Reaffirms Their Buy Rating on Cullinan Management (CGEM)

• TipRanks·03/11 10:15

  Cullinan: Advancing Immunology and Oncology Pipeline Undervalued; Buy Rating on CLN-978 Catalysts and Strong Cash Runway

• TipRanks·03/11 06:01

  Cullinan Management Adopts Reduced SEC Reporting: Lower Compliance Costs, But Potential Hit to Investor Appeal and Liquidity

• Benzinga·03/10 21:29

  Cullinan Therapeutics: Q4 Earnings Insights

• TipRanks·03/10 18:40

  Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM) and Mediwound (MDWD)

• TipRanks·03/10 16:50

  Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE)